T1	Value 14 32	18 to 80 years old
T2	Person 9 13	aged
R1	Has_value Arg1:T2 Arg2:T1	
T3	Condition 48 55	obesity
T4	Measurement 57 60	BMI
T5	Value 61 70	=25 kg/m2
T6	Condition 34 44	Overweight
*	OR T3 T6
T7	Scope 34 55	Overweight or obesity
R2	Has_value Arg1:T4 Arg2:T5	
R3	Subsumes Arg1:T7 Arg2:T4	
T8	Condition 95 110	type 2 diabetes
T9	Multiplier 123 135	at least one
T10	Temporal 73 81	Previous
T11	Temporal 166 173	current
T12	Drug 189 212	oral antidiabetic drugs
T13	Drug 220 227	insulin
*	OR T12 T13
T14	Scope 189 227	oral antidiabetic drugs and/or insulin
R4	Has_temporal Arg1:T14 Arg2:T11	
T15	Measurement 234 249	fasting glucose
T16	Value 256 271	above 126 mg/dl
R5	Has_value Arg1:T15 Arg2:T16	
T17	Multiplier 272 295	on at least 2 occasions
R6	Has_multiplier Arg1:T15 Arg2:T17	
T18	Measurement 300 319	blood glucose level
T19	Value 371 402	equal to or more than 200 mg/dl
T20	Temporal 320 367	at 2 hours after an oral glucose tolerance test
T21	Reference_point 337 367	an oral glucose tolerance test
T22	Procedure 340 367	oral glucose tolerance test
R7	multi Arg1:T21 Arg2:T22	
R8	Has_index Arg1:T20 Arg2:T21	
R9	Has_temporal Arg1:T18 Arg2:T20	
R10	Has_value Arg1:T18 Arg2:T19	
T23	Measurement 412 445	glycated hemoglobin (HbA1c) level
T24	Value 446 453	> 6.5 %
R11	Has_value Arg1:T23 Arg2:T24	
*	OR T23 T18 T15 T14
R12	Has_temporal Arg1:T8 Arg2:T10	
T25	Scope 166 453	current treatment with oral antidiabetic drugs and/or insulin; 2) a fasting glucose value above 126 mg/dl on at least 2 occasions; 3) blood glucose level at 2 hours after an oral glucose tolerance test is equal to or more than 200 mg/dl; or 4) a glycated hemoglobin (HbA1c) level > 6.5 %
R13	Has_multiplier Arg1:T25 Arg2:T9	
R14	Has_scope Arg1:T8 Arg2:T25	
T26	Condition 477 497	diabetic nephropathy
T27	Measurement 506 538	urinary albumin/creatinine ratio
T28	Value 539 547	>30 mg/g
R15	Has_value Arg1:T27 Arg2:T28	
T29	Measurement 555 591	estimated glomerular filtration rate
T30	Value 592 623	more than 20 ml/min per 1.73 m2
R16	Has_value Arg1:T29 Arg2:T30	
T31	Drug 657 697	angiotensin-converting enzyme inhibitors
T32	Multiplier 641 653	stable doses
T33	Drug 699 731	angiotensin II receptor blockers
T34	Drug 735 758	anti-aldosterone agents
T35	Temporal 759 781	in the last four weeks
*	OR T31 T33 T34
T36	Scope 657 758	angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers or anti-aldosterone agents
R17	Has_multiplier Arg1:T36 Arg2:T32	
R18	Has_temporal Arg1:T36 Arg2:T35	
